OIG Most Wanted Fugitives
The OIG most wanted fugitives list highlights individuals who are sought by the Office of Inspector General (OIG) for various serious crimes, including fraud and abuse. These fugitives have been charged with offenses that often impact government programs and taxpayer dollars.
Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
31 Entities in OIG Most Wanted Fugitives
| Entity Name | Entity Type | Effective Date | Status |
|---|---|---|---|
Daniel Guerra | Individual | Jun 18, 2024 | inactive |
Jahaziel Garcia Gonzalez | Individual | May 16, 2024 | inactive |
Nurista Grigoryan | Individual | Feb 8, 2024 | inactive |
Armando Zamora | Individual | Mar 12, 2024 | inactive |
Poul Thorsen | Individual | May 2, 2024 | inactive |
Ji Hae Kim | Individual | Nov 27, 2024 | active |
Ji Hae Kim | Individual | Nov 27, 2023 | inactive |
Oleg Kheyson | Individual | Jan 16, 2023 | inactive |
Jahaziel Garcia Gonzalez | Individual | May 16, 2023 | inactive |
Aiza Rodriguez | Individual | Mar 22, 2024 | inactive |
FAQs
Why is compliance with the Office of Research Integrity (ORI) - PHS Administrative Action Bulletin necessary?
Compliance with the PHS Administrative Action Bulletin issued by the Office of Research Integrity (ORI) is essential to maintain the integrity of research within public health. Adhering to these sanctions ensures that researchers uphold ethical standards, promoting trust and accountability in scientific studies. Non-compliance can lead to serious consequences, including disqualification from federal funding and potential legal repercussions. By following these guidelines, institutions can safeguard their reputation and contribute to the responsible advancement of scientific knowledge.
Which companies should comply with Office of Research Integrity (ORI) - PHS Administrative Action Bulletin?
Companies involved in biomedical research, healthcare, and clinical trials should comply with the Office of Research Integrity (ORI) PHS Administrative Action Bulletin. Compliance is essential to uphold research integrity, ensure ethical practices, and maintain public trust in scientific findings. Adhering to these guidelines helps prevent misconduct, safeguarding both the credibility of research and potential funding opportunities.
APIs
Data License
Solutions
Pricing
All rights reserved | Terms of use Copyright ©2025 Trademo Technologies Inc.